Join the RA-BRANCH Study Team

The RA-BRANCH Study is a multi-center safety study in adult patients with rheumatoid arthritis (RA). We are assessing the effects of treatment with baricitinib compared to treatment with tumor necrosis factor (TNF) inhibitors in patients receiving routine clinical care.

Sign-Up Now

Participation is Simple

The RA-BRANCH Study is a pragmatic clinical trial, which aims to measure the relative safety of treatment strategies in real-world clinical practice. The study design puts the focus on patients in the real world. We are looking for clinicians who regularly see adult patients with RA and are interested in participating in a clinical trial. Sign up to receive a Confidentiality Disclosure Agreement (CDA) so you can learn more information about the study design and reimbursement details.


Participation Benefits

Help move RA research forward by participating in the RA-BRANCH Study

Help move RA research forward

Compensation for participation in the RA-BRANCH Study

Compensation for participation

Identify how treatment for RA fares in a real world setting by participating in the RA-BRANCH Study

Better understand how treatment for RA fares in a real world setting

Take an active role in advancing science by participating in the RA-BRANCH Study

Take an active role in advancing science

About the RA-BRANCH Study

Rheumatoid arthritis (RA) is a common, systemic autoimmune inflammatory disease, characterized by synovial inflammation leading to pain, swelling, stiffness, and progressive destruction and deformity of small and large joints.

To help evaluate treatment options, we are conducting the RA-BRANCH Study designed to assess the safety of baricitinib in patients with RA receiving routine clinical care. Specifically, the study will compare safety endpoints among patients with RA that are randomized to either TNF inhibitors or baricitinib.

Sign-Up Now
1.3 million adults are affected by rheumatoid arthritis

1.3 million US adults
are affected by rheumatoid arthritis1

Patients with RA experience impaired physical function

Patients with RA
experience impaired physical function, decreased social participation, health-related quality of life

Mortality hazards are 60-70% higher

People with RA have
higher mortality
compared to people in the general population2

1Gabriel et al. 2003 (PMID 12528103); 2Helmick et al 2008 (PMID 18163481)

Patient and Doctor Talk

Frequently Asked Questions

Resources

Download the RA-BRANCH Confidentiality and Non-Use Agreement

RA-BRANCH Confidentiality and Non-Use Agreement

Download PDF

Download the RA-BRANCH Site Feasibility Survey

RA-BRANCH Site Feasibility Survey

Download PDF or,
Complete the form online

For more information on RA-BRANCH Study visit ClinicalTrials.gov

ClinicalTrials.gov

For more information,
click here

For more information on RA-BRANCH Study visit view the Lilly Trial Guide

 Lilly Trial Guide

For more information,
click here

mail_outline

Contact Us

If you have any questions and need more information about the RA-BRANCH Study, please contact us at
[email protected].